Recombinant expression vector applicable to rapid screening for recombinant strain and application
US-12037632-B2 · Jul 16, 2024 · US
US9410135B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9410135-B2 |
| Application number | US-201113822623-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2011 |
| Priority date | Sep 15, 2010 |
| Publication date | Aug 9, 2016 |
| Grant date | Aug 9, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to mutant thermostable glycosyl hydrolases family 7 enzymes, including mutant Trichoderma reesei endoglucanase I. In particular, the present disclosure relates to mutant thermostable enzymes, compositions containing the enzymes, and methods of use thereof.
Opening claim text (preview).
What is claimed is: 1. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; and an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine. 2. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 3. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 230 of SEQ ID NO: 1 with an amino acid selected from the group consisting of serine, threonine, leucine, methionine, lysine, alanine, glutamine, glutamic acid, and arginine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 4. A mutant thermostable endoglucanase I enzyme, wherein the mutant thermostable enzyme has an amino acid substitution at position 113 of SEQ ID NO: 1 with an amino acid selected from the group consisting of leucine and serine; and an amino acid substitution at position 115 of SEQ ID NO: 1 with an amino acid selected from the group consisting of threonine and glycine. 5. The mutant thermostable enzyme of claim 1 , wherein the enzyme exhibits increased thermostability as compared to the wild-type enzyme after incubation at about 50° C. for about one hour. 6. The mutant thermostable enzyme of claim 1 , wherein the enzyme has a specific activity of at least about 0.5 mMole GE/μMole enzyme/hr after incubation at about 50° C. for about one hour. 7. A composition comprising the mutant thermostable enzyme of claim 1 . 8. An isolated nucleic acid encoding the mutant thermostable enzyme of claim 1 . 9. An expression vector comprising the nucleic acid of claim 8 operably linked to a regulatory sequence. 10. A host cell comprising the expression vector of claim 9 . 11. A composition comprising the host cell of claim 10 and culture medium. 12. A method of reducing the viscosity of a pretreated biomass mixture, comprising: contacting a pretreated biomass mixture having an initial viscosity with the composition of claim 7 ; and incubating the contacted biomass mixture under conditions sufficient to reduce the initial viscosity of said pretreated biomass mixture. 13. A method of converting biomass to sugars comprising contacting the biomass with the composition of claim 7 . 14. A method of hydrolyzing or degrading biomass, comprising contacting the biomass with the composition of claim 7 . 15. A method of producing a fermentation product, comprising: contacting biomass with the composition of composition of claim 7 to form a first product; and culturing the first product with one or more fermentative microorganisms or a chemical solution under conditions sufficient to produce a fermentation product. 16. The method of claim 15 , wherein the contacting is conducted at a temperature between about 50° C. and about 55° C., between about 55° C. and about 60° C., or between about 60° C. to about 70° C. 17. A method of fermenting biomass, comprising: contacting biomass with one or more fermentative microorganisms, wherein the biomass is treated by the composition of claim 7 . 18. A method of producing a fuel comprising: contacting biomass with the composition of claim 7 to yield a sugar solution; and culturing the sugar solution with a fermentative microorganism or a chemical solution under conditions sufficient to produce a fuel. 19. The method of claim 18 , wherein the contacting is conducted at a temperature between about 50° C. and about 55° C., between about 55° C. and about 60° C., or between about 60° C. to about 70° C.
produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title
substrate containing cellulosic material · CPC title
Cross-Sectional Technologies · mapped topic
Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.